Research funder · United Kingdom
Brain Tumour Charity
British charity founded in 1996
- Grants since 2016
- 49
- Awarded, last 5 years (where amounts are published)
- £26.4M
- Funded works, last 5 years
- 390
- Funded works, all time
- 1 023
Grants
2026–2028 · grant · Medulloblastoma, Paediatric, Immunotherapy
Unraveling and immunotherapeutic targeting of medulloblastoma surfaceome
Poul Sorensen · University of British Columbia
2026–2030 · grant · Adult, high grade glioma
Targeting Treatment Resistance in Gliomas to Rapidly Push CAR-T Cell Therapies to Clinic
Christopher Mount · Massachusetts General Hospital
2026–2029 · grant · Adult, high grade glioma, DNA repair
Blocking DNA Repair in Gliomas to Overcome Resistance
Ola Rominiyi · University of Sheffield
2025–2026 · grant · Adult, High Grade, Glioblastoma, Translational
Evaluation of post-resection use of MTL-004 with standard of care in the treatment of primary glioblastoma
Michael Hudson · Gordian Pharma Ltd., United Kingdom
2025–2027 · grant · CNS tumours, Paediatric, Quality of Life, Clinical
The OUTLIVE project: towards a natiOnal qUaliTy of survival after brain tumours hIVE
2025–2027 · grant · Glioma, Adult, High grade, Low grade
TET-associated de-methylation-based tumour grading of IDH mutant gliomas
Youri Hoogstrate · Erasmus MC
2025–2030 · grant · Paediatric, high grade
Enhancing CAR-T Cell Therapy for Ependymoma: Targeted Reprogramming of the Tumour Microenvironment
Kristian Pajtler · Hopp Children’s Cancer Center Heidelberg And University College London
2025–2026 · grant · CNS tumours, Quality of Life, Paediatric, Clinical
Project THRIVE: The Development of Evidence-Based Actionable Guidelines for Non-Pharmacological Interventions that Improve Quality of Life Among Those Living Beyond a Paediatric Brain Tumour Diagnosis
Faye Didymus · Leeds Beckett University
2025–2027 · grant · High grade glioma, Adult
Advancing High Grade Glioma Diagnostics: Harnessing Novel Techniques in cf-DNA Technology
David Shultz · University Health Network
2025–2028 · grant · Paediatric, High-Grade, Glioma
Blocking Diffuse Midline Glioma by targeting HMGB2 chromatin factor
Luciano Di Croce · Centre for Genomic Regulation
2025–2027 · grant · Ependymoma, Immunotherapy, Paediatric, High grade
Tumour Defenders at the Brain’s Edge: Understanding how Skull-derived Haematopoietic Stem/Progenitor Cells Contribute to Ependymoma Immunotolerance
Elizabeth Cooper · University of Cambridge
2025–2027 · grant · Glioblastoma, virotherapy
Developing next generation virotherapies for glioblastoma
Emily Bates · Cardiff University
2025–2026 · grant · Paediatric, High grade, Low grade
Enhancing engineered immune cells to treat paediatric brain tumours
John Anderson · University College London
2025–2030 · grant · Adult, meningioma
Decoding the immunological landscape of meningioma to identify new treatment targets
Gelareh Zadeh · Mayo Clinic
2025–2026 · grant · Platform, Adult, High grade, Glioblastoma
Ultrasound-guided, multi-drug delivery for Glioblastoma
Maya Thanou · King's College London
2025–2028 · grant · Paediatric, High-grade, Glioma
Exploring the significance of the pontine brain microenvironment in shaping paediatric glioma invasive properties
Maria Alieva · Biomedical Research Institute Sols-morreale, Madrid
2025–2026 · grant · Paediatric, Imaging, Artificial Intelligence
Using AI to Help Diagnose Brain Tumours
John Apps · University of Birmingham
2025–2027 · grant · CNS tumours, Paediatric, Quality of Life
Learning Curve: First steps in the development of a co-designed programme to help childhood brain tumour survivors to succeed in school
Sarita Depani · Great Ormond Street Hospital
2025–2026 · grant · Paediatric, Quality of Life, CNS tumours, Clinical
Validating a structured fatigue intervention and exploring the impact on quality of life for paediatric brain tumour survivors
Vicky King · Cambridge University Hospitals NHS Foundation Trust
2024–2026 · grant · Glioblastoma (High grade), Adult, Academic
Glioma Brain Organoid Models of Glioblastoma Treatment Response
Lucy Stead · University of Leeds
2024–2029 · grant · Adult, High grade, Glioblastoma, Academic
Moving the needle in kinase-driven glioblastoma by achieving brain-specific pharmacology, improved residence time and resistance profiles with low molecular weight multi-topic compounds.
Pau Creixell · University of Cambridge
2024–2029 · grant · CNS tumours, Rare tumours, REST, Clinical
Improving treatments for patients with rare embryonal and sarcomatous CNS tumours
Katja Von Hoff · Aarhus University Hospital, Denmark / Alder Hey, Liverpool, Uk
2024–2027 · grant · Glioblastoma (High grade), Adult and paediatric gliomas, immunotherapy
Empirical determination of the in vivo immunopeptidome in paediatric and adult brain tumours to unlock neoantigens for immunotherapeutic use
Antonio Carlos Fuentes-Fayos · University Of Córdoba, Spain / Cedars-sinai Medical Center, Los Angeles
2024–2027 · grant · Glioblastoma (High grade)
T-Cell Receptor Sequencing for Non-Invasive Glioma Diagnostics and Monitoring
Bo Sun · University of Oxford
2024–2027 · grant · Meningioma
Defining and targeting the cellular origin of meningioma
Charlotte Eaton · University of California, San Francisco
2024–2027 · grant · Glioblastoma, immunotherapy
Manipulating T-cell immune responses in order to improve anti-Glioblastoma immunity
Mathew Clement · Cardiff University
2024–2026 · grant · Glioblastoma (High grade), Adult, Academic
Lipid Nanoparticles Nucleic Acids Delivery for Therapeutic Targets Identification for Glioblastoma Immunotherapy
Khuloud Al-Jamal · King's College London
2023–2025 · grant · Glioblastoma (High grade), Tumour biology, Academic
Exploring the immune cells in skull bone marrow to treat glioblastoma
Manish Aghi · University Of California, Usa
2023 · grant · Adult, High Grade, Quality of Life, Clinical, Recurrent Glioblastoma Brain Cancer
Clinical Trial of Cannabis Derivatives
Susan Short · University Of Leeds With The University Of Birmingham Clinical Trials Unit
2023–2026 · grant · Animal models, Biomarkers, Diagnosis, Medulloblastoma, Neuro-surgery, Posterior Fossa Tumours, Quality of life, Radiotherapy, Treatment side effects
Identifying a specific subtype of brain tumour without surgery to improve children’s quality of life
Jessica Taylor · University of Cambridge
2023–2027 · grant · Glioblastoma (High grade), Tumour biology, Academic, Junior Fellowship
Uncovering the role of tumour microenvironments in glioblastomas
Spencer Watson · University of Lausanne
2023–2028 · grant · Glioblastoma (High grade), Immunotherapy, Academic, Quest for cures
Fighting recurrent Glioblastomas with immunotherapy
Jun Ishihara · Imperial College London
2023–2028 · grant · Paediatric, Medulloblastoma (High grade), Academic, Tumour biology, Quest for cures
Growing model brains in the search for new treatments
Marcel Kool · Princess Máxima Center, Utrecht & University Of Oxford, Uk
2023–2025 · grant · Glioblastoma (GBM), Immunotherapy, Radiotherapy, Tumour Microenvironment
Shining a light on the role of lipid metabolism as a barrier to successful brain tumour treatment
Mara De Martino · Weill Cornell Medicine
2023–2025 · grant · Glioblastoma (High grade), Academic, Immunotherapy
Boosting the immune system to combat glioblastoma
Michael Brown · Central Adelaide Local Health Network
2023–2028 · grant · Paediatric, Gliomas (High grade), Academic, Quest for cures
Targeting non-dividing cells in childhood high-grade tumours
Juan Pedro Martinez-Barbera · University College London
2023–2025 · grant · DNA repair, Genomics, High Grade Glioma, Inhibitors, Neuro-surgery, Stem cells
Investigating DNA repair on a cell-by-cell basis in glioblastoma
Ola Rominiyi · University of Sheffield
2023–2027 · grant · Glioblastoma (High grade), Academic, Immunotherapy, Junior Fellowship
Reprogramming immune cells to increase treatment options for glioma patients
Tyler Miller · Case Western Reserve University School Of Medicine / University Hospitals Cleveland Medical Center
2022 · grant · Paediatric, Low Grade, Quality of Life
The Everest Centre
David Jones
2022–2028 · grant · Glioblastoma (High grade), Tumour Biology, DNA repair, Radiotherapy, Biomarkers
The Brain Tumour Charity Chair of Translational Neuro-oncology
Petra Hamerlik · University Of Manchester Cancer Research Centre (mcrc)